BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 19728761)

  • 1. Hormonal and metabolic evaluation of adrenal incidentalomas.
    Wagnerova H; Dudasova D; Lazurova I
    Neoplasma; 2009; 56(6):521-5. PubMed ID: 19728761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal incidentaloma: an overview of hormonal data from the National Italian Study Group.
    Mantero F; Masini AM; Opocher G; Giovagnetti M; Arnaldi G
    Horm Res; 1997; 47(4-6):284-9. PubMed ID: 9167966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas - hormonal and mutation screening.
    Wagnerova H; Lazúrová I; Habalová V; Dudásová D; Vrzgula A
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):272-5. PubMed ID: 18589890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo and in vitro studies on steroid metabolism in a case of primary aldosteronism with multiple lesions of adenoma and nodular hyperplasia.
    Honda M; Tsuchiya M; Tamura H; Watanabe H; Izumi Y; Hatano M; Shiratsuchi T; Den K; Kawaoi A; Okano T
    Endocrinol Jpn; 1982 Oct; 29(5):529-40. PubMed ID: 6303762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
    Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
    J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas).
    Osella G; Terzolo M; Borretta G; Magro G; Alí A; Piovesan A; Paccotti P; Angeli A
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1532-9. PubMed ID: 7989452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
    Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
    J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adrenal incidentaloma, clinical, metabolic, follow-up aspects: single centre experience.
    Comlekci A; Yener S; Ertilav S; Secil M; Akinci B; Demir T; Kebapcilar L; Bayraktar F; Yesil S; Eraslan S
    Endocrine; 2010 Feb; 37(1):40-6. PubMed ID: 19882253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hormonal evaluation and mutation screening for steroid 21-hydroxylase deficiency in patients with unilateral and bilateral adrenal incidentalomas.
    Patócs A; Tóth M; Barta C; Sasvári-Székely M; Varga I; Szücs N; Jakab C; Gláz E; Rácz K
    Eur J Endocrinol; 2002 Sep; 147(3):349-55. PubMed ID: 12213672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidentally discovered adrenal masses: a functional and morphological study.
    Corsello SM; Della Casa S; Bollanti L; Rufini V; Rota CA; Danza F; Colasanti S; Vellante C; Troncone L; Barbarino A
    Exp Clin Endocrinol; 1993; 101(3):131-7. PubMed ID: 8223980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of hormonal function in a series of incidentally discovered adrenal masses.
    Bondanelli M; Campo M; Trasforini G; Ambrosio MR; Zatelli MC; Franceschetti P; Valentini A; Pansini R; degli Uberti EC
    Metabolism; 1997 Jan; 46(1):107-13. PubMed ID: 9005978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidentally discovered adrenal tumors: endocrine and scintigraphic correlates.
    Barzon L; Scaroni C; Sonino N; Fallo F; Gregianin M; Macrì C; Boscaro M
    J Clin Endocrinol Metab; 1998 Jan; 83(1):55-62. PubMed ID: 9435416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Hormonal and morphologic characteristics of adrenal incidentalomas].
    Lazurova I; Wagnerova H; Zachar L; Schwartz P; Trejbal D; Bober J; Sokol L; Kovacova A
    Bratisl Lek Listy; 2000; 101(9):499-502. PubMed ID: 11187053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma").
    NIH Consens State Sci Statements; 2002 Feb 4-6; 19(2):1-25. PubMed ID: 14768652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PENTRAXIN 3 AS A NEW CARDIOVASCULAR MARKER IN ADRENAL ADENOMAS.
    Kizilgul M; Beysel S; Ozcelik O; Kan S; Apaydin M; Caliskan M; Ucan B; Sencar E; Ozdemir S; Cakal E
    Endocr Pract; 2017 Jun; 23(6):662-668. PubMed ID: 28332877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possibly simultaneous primary aldosteronism and preclinical Cushing's syndrome in a patient with double adenomas of right adrenal gland.
    Saito T; Ikoma A; Saito T; Tamemoto H; Suminaga Y; Yamada S; Kawakami M; Suzuki T; Sasano H; Ishikawa SE
    Endocr J; 2007 Apr; 54(2):287-93. PubMed ID: 17379961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Incidentaloma and subclinical disorders of the adrenal gland].
    Fischer E; Beuschlein F
    Dtsch Med Wochenschr; 2013 Feb; 138(8):375-80. PubMed ID: 23404326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endocrine Conditions in Older Adults: Adrenal Tumors.
    Ramsetty A; Bragg S; Bradford S; Bain J
    FP Essent; 2018 Nov; 474():28-32. PubMed ID: 30427650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal incidentaloma.
    Arnaldi G; Masini AM; Giacchetti G; Taccaliti A; Faloia E; Mantero F
    Braz J Med Biol Res; 2000 Oct; 33(10):1177-89. PubMed ID: 11004718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathological features of primary aldosteronism associated with subclinical Cushing's syndrome.
    Hiraishi K; Yoshimoto T; Tsuchiya K; Minami I; Doi M; Izumiyama H; Sasano H; Hirata Y
    Endocr J; 2011; 58(7):543-51. PubMed ID: 21521926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.